• Hydroxychloroquine prescribed to 300,000 more patients than usual after Trump endorsement

    28 days ago - By Daily Mail

    A new study from the CDC found that between February 2020 and March 2020, prescriptions for the anti-malaria drug hydroxychloroquine increase by 86.2% from 367, 346 to 683,999.
    Read more ...

     

  • Regeneron, Sanofi Arthritis Drug Fails Late-Stage Study in COVID-19 Patients

    Regeneron, Sanofi Arthritis Drug Fails Late-Stage Study in COVID-19 Patients

    28 days ago - By Medscape

    Regeneron Pharmaceuticals and Sanofi said on Thursday their rheumatoid arthritis drug Kevzara failed to meet the main goals of a late-stage study testing it in COVID-19 patients.
    Reuters Health Information
    Read more ...

     

  • Study: Adverse drug reactions common, many deemed preventable, in patients with CKD

    28 days ago - By Healio

    A study conducted in France found adverse drug reactions were common in patients with chronic kidney disease, most notably due antithrombotic agents, but researchers suggested many of these reactions may be preventable.
    While drug-related nephrotoxicity is a frequent and well-documented issue for patients with CKD, an understudied area involves medications and toxic metabolites that accumulate in the kidneys and can lead to adverse drug reactions as kidney function declines, according to Solène M. Laville, of Paris-Saclay University, and colleagues.
    “Despite impaired
    Read more ...